Safety and immunogenicity of a zoster vaccine in varicella-zoster virus seronegative and low-seropositive healthy adults
- 27 November 2006
- Vol. 25 (11) , 2139-2144
- https://doi.org/10.1016/j.vaccine.2006.11.011
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The incidence of herpes zoster in a United States administrative databaseJournal of General Internal Medicine, 2005
- A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older AdultsNew England Journal of Medicine, 2005
- Varicella Seroprevalence and Molecular Epidemiology of Varicella-Zoster Virus in Argentina, 2002Journal of Clinical Microbiology, 2004
- Herpes ZosterNew England Journal of Medicine, 2002
- High seroprevalence of antibodies to varicella zoster virus in adult women in a tropical climateTropical Medicine & International Health, 2000
- Varicella-Zoster Virus Epidemiology-A Changing Scene?The Journal of Infectious Diseases, 1996
- Postherpetic Neuralgia — Pathogenesis, Treatment, and PreventionNew England Journal of Medicine, 1996
- The incidence of herpes zosterArchives of internal medicine (1960), 1995
- The age of infection with varicella-zoster virus in St Lucia, West IndiesEpidemiology and Infection, 1993
- Antibody assays suitable for assessing immune responses to live varicella vaccineVaccine, 1991